drugset / Trial / NCT02957630
"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
RandomizedParallel-groupOpen-labelPrevention
Summary
The proposed study will provide an assessment of the effect of this combination on endocrine function, metabolic control and hemostasis during 6 treatment cycles. This will be compared to the effects of two reference COCs.
Timeline
- Start
- 2016-09
- Primary completion
- 2017-10-09
- Completion
- 2017-10-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ESTETROL ANHYDROUS | Other / unclassified | 15 mg | Oral |
| Comparator | Levonorgestrel | Small molecule | 150 ug | Oral |
| Subject | drospirenone | Unknown | 3 mg | Oral |
| Comparator | ethinyl estradiol | Small molecule | 20 ug | Oral |
| Comparator | ethinyl estradiol | Small molecule | 30 ug | Oral |
Indications
No indication recorded.